Morning Water Study

NCT07256587 · tracked via the Priya Life Science USA tracker

Sponsor

Efforia, Inc

Phase

Not applicable

Started

2025-08-23

Last updated

2025-12-23

Condition(s) studied

Energy

Investigational drug(s) / intervention(s)

Drink 24 ounces of water

Drink 24 ounces of water: Participants are asked to drink 24 ounces of water first thing upon waking in the morning for 30 days.

Study summary

This study aims to determine the efficacy of morning water consumption on reducing fatigue and boosting daily productivity. Participants will receive personalized feedback on how their morning hydration influences their energy levels, enabling them to make informed decisions on optimizing their daily performance for a more energized life.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Accepted

Inclusion Criteria: * all individuals over the age of consent Exclusion Criteria: * Individuals with Hyponatremia * Individuals with Kidney Issues * Individuals with Gastrointestinal Disorders * Individuals in Occupations with Limited Bathroom Access * Individuals with Fluid Restrictions * Individuals Prone to Electrolyte Imbalance

Primary outcome measure(s)

PROMIS Short Form v1.0 - Fatigue 8a — Baseline and 30 days
PROMIS Short Form v1.0 - Fatigue 8a
Neuro-QOL Item Bank v1.0 -Fatigue - Short Form — Baseline and 30 days
Neuro-QOL Item Bank v1.0 -Fatigue - Short Form

Trial sites (1)

Facility	City	Region	Status
Efforia	New York	New York

More Efforia, Inc trials in the USA

Sun-Kissed Serenity: Morning Rays for a Brighter Mind Enrolling by invitation

Beef Versus Whey Protein: The Gut Showdown Self-Experiment Active, not recruiting

Evaluating Heart & Soil's Lifeblood on Iron and Energy Levels Recruiting

Sound Stops Stress Study: Evaluating the WAVwatch Effect Recruiting

Evaluating Heart & Soil's Whole Package on Men's Health Active, not recruiting

Other trials for the same condition

Evaluating Heart & Soil's Lifeblood on Iron and Energy Levels Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07256587 on ClinicalTrials.gov ↗ ← All trials in the USA